Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies

Nicole C. Panarelli, Dara S. Ross, Oren E. Bernheim, Zachary B. Landzberg, Audrey N. Schuetz, Stephen G. Jenkins, Brian R. Landzberg, Jose Jessurun, Rhonda K. Yantiss

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Documentation of Helicobacter pylori infection and eradication is important, prompting some clinicians and pathologists to request ancillary stains on all gastric samples that do not demonstrate H. pylori on initial histologic review. Studies evaluating the utility of ancillary stains in patients with minimal inflammation are lacking. We used Giemsa, Warthin-Starry, acridine orange, and immunohistochemical stains to search for organisms in 56 patients with biochemical evidence of H. pylori infection (positive Campylobacter-like organism test) and gastric mucosal samples interpreted to be H pylori negative by hematoxylin and eosin (H&E). We correlated the findings with severity of inflammation and patients' histories of medication use. Nineteen (34%) patients had histologically normal mucosae, 22 (39%) had chronic inflammation with or without focal activity, and 15 (27%) had chemical gastropathy. Fifty (89%) cases were negative for H. pylori with additional stains, and 6 contained bacteria that were detected with all 4 ancillary stains and on retrospective review of H&E-stained sections that also showed chronic inflammation. Eleven (20%) patients were taking proton pump inhibitors, and 4 (7%) had previously received H. pylori eradication therapy. We conclude that H&E stains demonstrate H. pylori in most infected patients, so preemptive stain requests are largely unnecessary. Failure to identify bacteria by H&E evaluation generally reflects their absence in biopsy material, even among Campylobacter-like organism test - positive patients. However, organisms may be overlooked in patients with mild inflammation and in those receiving proton pump inhibitor or antibiotic therapy, so one should consider ordering ancillary stains to enhance detection of bacteria in these settings.

Original languageEnglish (US)
Pages (from-to)397-403
Number of pages7
JournalHuman Pathology
Volume46
Issue number3
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

Fingerprint

Helicobacter pylori
Stomach
Coloring Agents
Biopsy
Inflammation
Campylobacter
Proton Pump Inhibitors
Helicobacter Infections
Bacteria
Acridine Orange
Pylorus
Hematoxylin
Eosine Yellowish-(YS)
Documentation
Mucous Membrane
Anti-Bacterial Agents
Therapeutics

Keywords

  • Acridine orange
  • Chronic gastritis
  • Giemsa
  • Immunohistochemistry
  • Warthin-Starry

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Panarelli, N. C., Ross, D. S., Bernheim, O. E., Landzberg, Z. B., Schuetz, A. N., Jenkins, S. G., ... Yantiss, R. K. (2015). Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies. Human Pathology, 46(3), 397-403. https://doi.org/10.1016/j.humpath.2014.11.014

Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies. / Panarelli, Nicole C.; Ross, Dara S.; Bernheim, Oren E.; Landzberg, Zachary B.; Schuetz, Audrey N.; Jenkins, Stephen G.; Landzberg, Brian R.; Jessurun, Jose; Yantiss, Rhonda K.

In: Human Pathology, Vol. 46, No. 3, 01.03.2015, p. 397-403.

Research output: Contribution to journalArticle

Panarelli, NC, Ross, DS, Bernheim, OE, Landzberg, ZB, Schuetz, AN, Jenkins, SG, Landzberg, BR, Jessurun, J & Yantiss, RK 2015, 'Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies', Human Pathology, vol. 46, no. 3, pp. 397-403. https://doi.org/10.1016/j.humpath.2014.11.014
Panarelli, Nicole C. ; Ross, Dara S. ; Bernheim, Oren E. ; Landzberg, Zachary B. ; Schuetz, Audrey N. ; Jenkins, Stephen G. ; Landzberg, Brian R. ; Jessurun, Jose ; Yantiss, Rhonda K. / Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies. In: Human Pathology. 2015 ; Vol. 46, No. 3. pp. 397-403.
@article{303461db7df84a7cb072c80c8c3d5614,
title = "Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies",
abstract = "Documentation of Helicobacter pylori infection and eradication is important, prompting some clinicians and pathologists to request ancillary stains on all gastric samples that do not demonstrate H. pylori on initial histologic review. Studies evaluating the utility of ancillary stains in patients with minimal inflammation are lacking. We used Giemsa, Warthin-Starry, acridine orange, and immunohistochemical stains to search for organisms in 56 patients with biochemical evidence of H. pylori infection (positive Campylobacter-like organism test) and gastric mucosal samples interpreted to be H pylori negative by hematoxylin and eosin (H&E). We correlated the findings with severity of inflammation and patients' histories of medication use. Nineteen (34{\%}) patients had histologically normal mucosae, 22 (39{\%}) had chronic inflammation with or without focal activity, and 15 (27{\%}) had chemical gastropathy. Fifty (89{\%}) cases were negative for H. pylori with additional stains, and 6 contained bacteria that were detected with all 4 ancillary stains and on retrospective review of H&E-stained sections that also showed chronic inflammation. Eleven (20{\%}) patients were taking proton pump inhibitors, and 4 (7{\%}) had previously received H. pylori eradication therapy. We conclude that H&E stains demonstrate H. pylori in most infected patients, so preemptive stain requests are largely unnecessary. Failure to identify bacteria by H&E evaluation generally reflects their absence in biopsy material, even among Campylobacter-like organism test - positive patients. However, organisms may be overlooked in patients with mild inflammation and in those receiving proton pump inhibitor or antibiotic therapy, so one should consider ordering ancillary stains to enhance detection of bacteria in these settings.",
keywords = "Acridine orange, Chronic gastritis, Giemsa, Immunohistochemistry, Warthin-Starry",
author = "Panarelli, {Nicole C.} and Ross, {Dara S.} and Bernheim, {Oren E.} and Landzberg, {Zachary B.} and Schuetz, {Audrey N.} and Jenkins, {Stephen G.} and Landzberg, {Brian R.} and Jose Jessurun and Yantiss, {Rhonda K.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.humpath.2014.11.014",
language = "English (US)",
volume = "46",
pages = "397--403",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Utility of ancillary stains for Helicobacter pylori in near-normal gastric biopsies

AU - Panarelli, Nicole C.

AU - Ross, Dara S.

AU - Bernheim, Oren E.

AU - Landzberg, Zachary B.

AU - Schuetz, Audrey N.

AU - Jenkins, Stephen G.

AU - Landzberg, Brian R.

AU - Jessurun, Jose

AU - Yantiss, Rhonda K.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Documentation of Helicobacter pylori infection and eradication is important, prompting some clinicians and pathologists to request ancillary stains on all gastric samples that do not demonstrate H. pylori on initial histologic review. Studies evaluating the utility of ancillary stains in patients with minimal inflammation are lacking. We used Giemsa, Warthin-Starry, acridine orange, and immunohistochemical stains to search for organisms in 56 patients with biochemical evidence of H. pylori infection (positive Campylobacter-like organism test) and gastric mucosal samples interpreted to be H pylori negative by hematoxylin and eosin (H&E). We correlated the findings with severity of inflammation and patients' histories of medication use. Nineteen (34%) patients had histologically normal mucosae, 22 (39%) had chronic inflammation with or without focal activity, and 15 (27%) had chemical gastropathy. Fifty (89%) cases were negative for H. pylori with additional stains, and 6 contained bacteria that were detected with all 4 ancillary stains and on retrospective review of H&E-stained sections that also showed chronic inflammation. Eleven (20%) patients were taking proton pump inhibitors, and 4 (7%) had previously received H. pylori eradication therapy. We conclude that H&E stains demonstrate H. pylori in most infected patients, so preemptive stain requests are largely unnecessary. Failure to identify bacteria by H&E evaluation generally reflects their absence in biopsy material, even among Campylobacter-like organism test - positive patients. However, organisms may be overlooked in patients with mild inflammation and in those receiving proton pump inhibitor or antibiotic therapy, so one should consider ordering ancillary stains to enhance detection of bacteria in these settings.

AB - Documentation of Helicobacter pylori infection and eradication is important, prompting some clinicians and pathologists to request ancillary stains on all gastric samples that do not demonstrate H. pylori on initial histologic review. Studies evaluating the utility of ancillary stains in patients with minimal inflammation are lacking. We used Giemsa, Warthin-Starry, acridine orange, and immunohistochemical stains to search for organisms in 56 patients with biochemical evidence of H. pylori infection (positive Campylobacter-like organism test) and gastric mucosal samples interpreted to be H pylori negative by hematoxylin and eosin (H&E). We correlated the findings with severity of inflammation and patients' histories of medication use. Nineteen (34%) patients had histologically normal mucosae, 22 (39%) had chronic inflammation with or without focal activity, and 15 (27%) had chemical gastropathy. Fifty (89%) cases were negative for H. pylori with additional stains, and 6 contained bacteria that were detected with all 4 ancillary stains and on retrospective review of H&E-stained sections that also showed chronic inflammation. Eleven (20%) patients were taking proton pump inhibitors, and 4 (7%) had previously received H. pylori eradication therapy. We conclude that H&E stains demonstrate H. pylori in most infected patients, so preemptive stain requests are largely unnecessary. Failure to identify bacteria by H&E evaluation generally reflects their absence in biopsy material, even among Campylobacter-like organism test - positive patients. However, organisms may be overlooked in patients with mild inflammation and in those receiving proton pump inhibitor or antibiotic therapy, so one should consider ordering ancillary stains to enhance detection of bacteria in these settings.

KW - Acridine orange

KW - Chronic gastritis

KW - Giemsa

KW - Immunohistochemistry

KW - Warthin-Starry

UR - http://www.scopus.com/inward/record.url?scp=84924606658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924606658&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2014.11.014

DO - 10.1016/j.humpath.2014.11.014

M3 - Article

VL - 46

SP - 397

EP - 403

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 3

ER -